Ferroptosis: A potential therapeutic target in autoimmune disease (Review)

Exp Ther Med. 2023 Jun 15;26(2):368. doi: 10.3892/etm.2023.12067. eCollection 2023 Aug.

Abstract

Ferroptosis is a distinct type of regulated cell death characterized by iron overload and lipid peroxidation. Ferroptosis is regulated by numerous factors and controlled by several mechanisms. This cell death type has a relationship with the immune system, which may be regulated by damage-associated molecular patterns. Ferroptosis participates in the progression of autoimmune diseases, including autoimmune hepatitis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, Parkinson's Disease, psoriasis and insulin-dependent diabetes mellitus. The present review summarizes the role of ferroptosis in autoimmune disorders and discusses ferroptosis as a potential therapeutic target for autoimmune disease.

Keywords: autoimmune disease; ferroptosis; immune system; therapeutic target.

Publication types

  • Review

Grants and funding

Funding: The present study was supported by the Zhejiang Provincial Science Foundation of China (grant no. LGF21H020006), the Pioneer Innovation Team of Jiaxing Institute of Atherosclerotic Diseases (grant no. XFCX-DMYH), Program of the First Hospital of Jiaxing (grant no. 2021-YA-001), the Jiaxing Key Laboratory of Arteriosclerotic Diseases (grant no. 2020-dmzdsys) and Jiaxing Key Laboratory of Virus-mediated Infectious Diseases (grant no. 2021-bdzdsys).